★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

News/Compliance & Enforcement/Jury Finds Global Health Care Company Novo Nordisk Not Liable in Whistleblower’s FCA Suit
Expert Opinion·Compliance & Enforcement Brief

Jury Finds Global Health Care Company Novo Nordisk Not Liable in Whistleblower’s FCA Suit

Arent Fox Schiff – A federal jury in Washington state found Novo Nordisk not liable for violations of the False Claims Act (FCA), Anti-Kickback Statute, Washington False Claims Act, and Washington Fraudulent Practices Act relating to the promotion of its hemophilia drug NovoSeven.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.